Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 3, 2022Journal of Investigative DermatologyOpen Access

From Empirical to Pathogenesis-Based Treatments for Psoriasis

View Full Paper
Ask AI
Bookmark
Share

Authors

PKP.C.M. van de Kerkhof

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

P.C.M. van de Kerkhof (2022) studied this question.

synapsesocial.com/papers/6a77b461df493903fd1f222dhttps://doi.org/10.1016/j.jid.2022.01.014
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Blockade of T Lymphocyte Costimulation with Cytotoxic T Lymphocyte–Associated Antigen 4–Immunoglobulin (Ctla4ig) Reverses the Cellular Pathology of Psoriatic Plaques, Including the Activation of Keratinocytes, Dendritic Cells, and Endothelial Cells2000 · 319 citations
  2. 2IL-17 Is Produced by Nickel-Specific T Lymphocytes and Regulates ICAM-1 Expression and Chemokine Production in Human Keratinocytes: Synergistic or Antagonist Effects with IFN-γ and TNF-α1999 · 308 citations
  3. 3Comparison of Biologics and Oral Treatments for Plaque Psoriasis2020 · 294 citations
  4. 4The treatment of psoriasis with IL-10: rationale and review of the first clinical trials2000 · 54 citations
  5. 5Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis2019 · 293 citations